Pepdexpepdex
My Stack
№ 023

Survodutide

A weight-loss drug built for a stronger fat-burn signal than GLP-1-only options. A dual agonist (GLP-1 + glucagon) from Boehringer Ingelheim / Zealand Pharma, where glucagon activation boosts metabolic rate.

Fat Loss
Evidence: Moderate

Survodutide: A weight-loss drug built for a stronger fat-burn signal than GLP-1-only options. A dual agonist (GLP-1 + glucagon) from Boehringer Ingelheim / Zealand Pharma, where glucagon activation boosts metabolic rate. Survodutide is Boehringer Ingelheim's dual agonist (GLP-1 + glucagon), a competitor to Retatrutide.

FDA ⓘ
Not approved
WADA
Not banned
Typical dose
Start 0.3 mg sub-q weekly
Half-life ⓘ
~6 days
Route ⓘ
Subcutaneous
Schedule
Once weekly
In plain English

Survodutide is Boehringer Ingelheim's dual agonist (GLP-1 + glucagon), a competitor to Retatrutide. Stronger fat-burn signal than the GLP-1-only drugs because it activates glucagon, which boosts metabolic rate. Phase 2 data is promising. Once-weekly.

Status & legalityWhat do these mean? →
Natty? ⓘ
Not natty
FDA ⓘ
Not approved

Investigational. Phase 3 trials by Boehringer Ingelheim and Zealand Pharma (co-developers).

Compounding ⓘ
Investigational

In clinical trials, not yet approved for prescription.

WADA ⓘ
Not listed
Prescribed ⓘ

Not yet approved. Trial access only.

Who it's for

  • →Users plateaued on GLP-1-only drugs
  • →People targeting >15% body weight loss
  • →Phase 2 / 3 trial-followers wanting cutting-edge

What to expect

  1. Week 1

    Appetite drops. Mild nausea. Slight body-temp uptick (glucagon thermogenesis).

  2. Week 4

    First titration step. ~3-6 lb down for most users.

  3. Week 8

    Cumulative loss building steadily. Phase 3 topline was ~16.6% at 76 weeks, below Retatrutide but well above GLP-1-only options.

Looking at Survodutide? Your next 3 steps

  1. 1Work out your exact dose

    Vial size + BAC water turns into the exact units to draw for Survodutide.

    Open calculator →
  2. 2See what to stack & monitor

    The companion supplements and the bloodwork worth tracking on this kind of protocol.

    Bloodwork guide →
  3. 3Save it & ask the Coach

    A free account saves your stack; membership adds the stack-aware AI Coach.

    Create free account →

How it works (mechanism)

GLP-1 + glucagon dual agonist (no GIP). Different combination than Retatrutide, pairs satiety with thermogenesis, skipping the GIP arm.

Dosing protocol

Members only

Stacks well with

Members only

Side effects

01Nausea (especially titration steps)
02Diarrhea or constipation
03Mild fatigue
04Slightly elevated heart rate (glucagon effect)

When NOT to use

  • ⚠MTC / MEN-2 history
  • ⚠Pancreatitis history
  • ⚠Pregnancy / nursing
  • ⚠Severe cardiovascular disease

Bloodwork to monitor

  • • Lipid panel
  • • ALT/AST
  • • A1C

Common mistakes

  • • Titrating too fast
  • • Treating elevated HR as 'caffeine sensitivity'
  • • Not adjusting protein during the cut

Drug & supplement interactions

  • ⚠Insulin and sulfonylureas: dose reduction needed
  • ⚠Glucagon arm: monitor HR; caution with stimulants
  • ⚠Trial-only, full interaction profile not yet published

Community patterns

Members only
Free, no account needed

New to Survodutide? Grab the starter checklist.

Drop your email and we'll send the one-page first-cycle starter checklist, plus a heads-up if Survodutide changes legal status. No account needed.

No spam. No selling your email. Just the checklist and the occasional reclassification alert.

AI Coach, live sample
Members only
is 250mcg of bpc enough for a knee injury?
For a knee, 250 mcg sub-q daily is the standard working dose and a solid place to start. The trick with BPC is consistency, give it weeks, not days. Inject close to the joint, run it 4-6 weeks, and don't drop below 200 mcg, it tends to stop cracking the threshold reliably down there. If it hasn't moved at all by week 3, that's when adding TB-500 earns its place.
how much bac water for a 10mg reta vial?
3 mL is the standard play for a 10 mg reta vial. That's 3,333 mcg/mL, clean unit math across the titration: 2 mg = 60 units, 4 mg = 120 units, 6 mg = 180 units on a 100-unit insulin syringe. Run 2 mL instead if you want fewer, more concentrated shots (5,000 mcg/mL, so 2 mg = 40 units). Since most people titrate up over ~12 weeks, 3 mL keeps the numbers cleanest.
what should i track on bloodwork for tirzepatide?
Lipid panel, ALT/AST (liver enzymes), and an A1C, baseline before you start then every 3 months. If you've got metabolic-syndrome history, add fasting glucose and insulin so you can actually watch insulin sensitivity improve. You don't need a big hormone panel for a GLP-1.

Ask the Coach anything about Survodutide or your own stack. This is it working.

Trained only on Pepdex content. Does the dose math, flags interactions, knows your stack. Won't push vendors, won't pretend to be a doctor.

Get the Coach, $7.99/mo →

Frequently asked

What is Survodutide?+
Survodutide is Boehringer Ingelheim's dual agonist (GLP-1 + glucagon), a competitor to Retatrutide. Stronger fat-burn signal than the GLP-1-only drugs because it activates glucagon, which boosts metabolic rate. Phase 2 data is promising. Once-weekly.
Is Survodutide FDA approved?+
Investigational. Phase 3 trials by Boehringer Ingelheim and Zealand Pharma (co-developers).
Is Survodutide legal?+
Survodutide is not FDA-approved. It is sold by compounding pharmacies (with a prescription) and as "research only" by peptide vendors. Possession is generally not criminalized but distribution without authorization may be. Verify local laws.
Is Survodutide banned by WADA?+
Survodutide is not currently on the WADA prohibited list.
Are you still natty after taking Survodutide?+
No. Survodutide is a performance-enhancing peptide and would disqualify a strict natty claim.
Do doctors prescribe Survodutide?+
Not yet approved. Trial access only.
What's the typical dose of Survodutide?+
Start 0.3 mg sub-q weekly. Titrate over 4-week steps up to 6.0 mg in trials.
What are the side effects of Survodutide?+
Common side effects include: Nausea (especially titration steps); Diarrhea or constipation; Mild fatigue; Slightly elevated heart rate (glucagon effect). Less common effects and full safety details are on the entry page.
How long until Survodutide starts working?+
Appetite drops. Mild nausea. Slight body-temp uptick (glucagon thermogenesis).
What can you stack with Survodutide?+
Common pairings: Standalone is the norm. Full stacking protocol and timing on the entry page.
Where do people get Survodutide?+
Survodutide is most commonly sold by research-only peptide vendors and by compounding pharmacies (the latter requires a prescription). Pepdex is not a vendor, see /coa for how to verify a Certificate of Analysis before buying from any source, and /guides/scam-vendor-spotting for vendor red flags.
Survodutide vs Mazdutide, which is better?+
Mazdutide vs Survodutide: two late-stage GLP-1 + glucagon dual agonists. Innovent vs Boehringer Ingelheim development paths. Full head-to-head comparison: https://pepdex.co/compare/mazdutide-vs-survodutide

Head-to-head with Survodutide

Compare
Survodutide vs Mazdutide →

More in Fat Loss

№ 008
Tirzepatide

Strong weight loss with a cleaner side effect profile than semaglutide. A dual agonist (GLP-1 + GIP), FDA-approved as Mounjaro / Zepbound.

№ 009
Semaglutide

The original weight-loss wave, sold as Ozempic / Wegovy. A GLP-1 agonist.

№ 003
Retatrutide

Triple agonist (GLP-1 + GIP + glucagon) from Eli Lilly. In trials it outperforms Tirzepatide for weight loss.

№ 058
Liraglutide (Saxenda / Victoza)

Daily GLP-1 receptor agonist. FDA-approved 2010 (Victoza, T2D) and 2014 (Saxenda, obesity). The first wave of modern GLP-1 weight-loss therapy and direct predecessor to Semaglutide.